Delayed Danish state Covid vaccine to be trialled on humans in 2022
![Seruminstituttets chefvirolog Anders Fomsgaard siger, at man er tæt på | Photo: Tobias Nicolai/IND](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13224551.ece/ALTERNATES/schema-16_9/doc7h8fj5z7jkj3cdm5mob.jpg)
Denmark's second coronavirus vaccine, Covaxix, which is being developed by National Danish infectious disease research organization Statens Serum Insitut (SSI), has come closer to being tested on humans in phase I and II trials in 2022 after a string of delays.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.